Other highlights in the November 19 issue of JNCI

November 18, 2003

Study Exposes Racial Disparities in Treatment Outcomes Black men tend to have poorer overall survival than white men after being treated for localized prostate cancer, according to a new study, which also found that the disparity is greatest among men who undergo surgery.

In a study that examined the records of 5,747 black men and 38,242 white men with clinically localized prostate cancer, Paul A. Godley, M.D., Ph.D., of the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, and his colleagues found that overall median survival time for black patients was 1.7 years less than that for white patients. Among patients who received surgery, black patients survived a median 1.8 years less than white patients (10.8 years vs. 12.6 years, respectively). The differences in median survival between black and white patients were smaller among patients treated with radiation and among patients who received nonaggressive treatment.

The authors explain that black patients with locally advanced prostate cancer may have had less access to specialized radiation therapy, which is preferred over surgery. Alternatively, there may be biologic factors that affect response to prostate cancer treatment. "Researchers should continue to investigate racial disparities in treatment outcomes as well as the specific social, biologic, or environmental conditions that may be responsible for these disparities," the authors conclude.

Contact: Dianne Shaw, Lineberger Comprehensive Cancer Center, 919-966-7834, dgs@med.unc.edu.

Genetic Disorder May Predispose Patients to HPV-Induced Cancers The rare genetic disorder Fanconi anemia may be associated with an increased susceptibility to human papillomavirus (HPV)-associated cancers, including squamous cell carcinoma (SCC), according to a new study. David I. Kutler, M.D., and Bhuvanesh Singh, M.D., of the Memorial-Sloan-Kettering Cancer Center in New York, and their colleagues examined SCC samples from 24 patients with Fanconi anemia and 50 patients without Fanconi anemia, and found that 84% of samples from patients with Fanconi anemia contained HPV DNA, compared with only 36% of samples from patients without Fanconi anemia. Patients with Fanconi anemia and SCC were also more likely than patients without SCC to have a specific polymorphism in the p53 gene that may be associated with an increased risk for HPV-associated cancers.

Contact: Joanne Nicholas, Memorial Sloan-Kettering Cancer Center, 212-639-3573, nicholaj@mskcc.org.

Study May Explain How Peptide Promotes Cancer Spread New research suggests that the small peptide thymosin beta4 stimulates cancer metastasis by activating cell migration and angiogenesis (the formation of new blood vessels). Hee-Jae Cha and Hynda K. Kleinman, Ph.D., of the National Institute of Dental and Craniofacial Research, and their colleagues showed that mice injected with cells derived from metastatic lung tumors that expressed thymosin beta4 developed larger tumors and more metastatic lung nodules than mice injected with cells that did not express thymosin beta4. Thymosin beta4 overexpression was associated with increases in cancer cell migration and the number of blood vessels in solid tumors, but had no effect of cell invasion, proliferation, or matrix metalloproteinase activity. In addition, overexpression of thymosin beta4 was associated with increased expression of vascular endothelial growth factor, which is involved in tumor angiogenesis.

Contact: Bob Kuska, National Institute of Dental and Craniofacial Research, 301-594-7560, kuskar@nidcr.nih.gov.

Moderate Drinking Associated with Higher Hormone Levels Postmenopausal women who consume moderate amounts of alcohol (roughly one to two drinks per day) may be at an increased risk for cancer because of increased blood serum levels of the fat hormone leptin, according to a new study. Mark J. Roth, M.D., of the National Cancer Institute, and his colleagues examined serum leptin levels in 53 healthy, nonsmoking postmenopausal women who received one drink (15 g of alcohol), two drinks (30 g of alcohol), or zero drinks per day to elucidate possible mechanisms by which alcohol may affect cancer risk. Women who consumed one or two drinks per day had higher serum leptin levels than women who consumed zero drinks per day. Younger women (ages 49 to 54) had a greater association between alcohol consumption and serum leptin levels than older women (ages 55 to 79). The authors say that more research is needed to determine whether alcohol consumption can potentiate the effect of serum leptin on cancer risk.

Contact: NCI Press Office, 301-496-6641, ncipressofficers@mail.nih.gov.

Titles of additional articles appearing in the November 19 JNCI:
Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Journal of the National Cancer Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.